More Americans than expected enrolled in Affordable Care Act health insurance plans for this year, after premium subsidies were dramatically cut — but it remains to be seen whether they’ll keep the coverage as their costs mount. It’s all part of a drama that roiled the ACA’s 2026 open enrollment period. Congressional debate over whether…
The current Affordable Care Act open enrollment season is the first big test of new federal guardrails against fraud. The rules aim to head off unauthorized ACA plan enrollments or switches by rogue agents and entities looking to make money via enrollment commissions. Such sign-ups triggered more than 274,000 consumer complaints through August this year….
President Trump has been pursuing policies intended to entice drugmakers to bring manufacturing and jobs to the U.S. GSK’s announcement makes it the latest big pharma company to unveil a multi-billion dollar plan for new U.S. facilities. The post GSK Plans to Spend $30B on U.S. Manufacturing and R&D Infrastructure Over the Next 5 Years…
“People are not picking up their medicine; they’re not seeing the doctor,” St. John’s Community Health clinics’ CEO says
Susan Monarez has left her role as CDC director after less than a month — the shortest tenure in the agency’s history — following reported clashes with HHS Secretary Robert F. Kennedy Jr. over vaccine policy. This news comes amid a period of turmoil at the CDC, including a recent deadly shooting at its headquarters….
Applications of SandboxAQ’s large quantitative models (LQMs) technology include running simulations that identify new biomarkers and optimize clinical development of drug candidates. The company spun out of Alphabet in 2022. The post AI Tech Firm SandboxAQ Adds $300M to Ramp Up Development of LQMs for Drug Discovery & More appeared first on MedCity News.
This budget summary provides an analysis of global health funding amounts provided in the House FY 2026 Labor, Health and Human Services, Education, and Related Agencies (Labor HHS) appropriations bill and accompanying report.
Etiome’s precision medicine approach introduces a temporal component to treating disease — drugs developed specifically to treat disease at particular points in time even before symptoms show. The Flagship Pioneering startup’s approach offers the potential to prevent disease; in cases where disease is already present, Etiome aims to halt or even reverse it. The post…
The contraceptive implant is the most effective method of birth control available, and while it’s use is still low compared to other methods, its provision and use are increasing.
Johnson & Johnson announced last week a major change in the way it offers 340B pricing for two medications. The change is “inconsistent” with the 340B statute, according to HRSA. The post J&J’s Change to 340B Discounts is “Inconsistent” with Statute, HRSA Says appeared first on MedCity News.